Cargando…

Red cell distribution width associations with clinical outcomes: A population-based cohort study

IMPORTANCE: Higher levels of red cell distribution width (RDW) are associated with adverse outcomes, especially in selected cohorts with or at risk for chronic disease. Whether higher RDW or the related parameter standard deviation of the red blood cell distribution (SD-RBC) can predict a broader ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Tonelli, Marcello, Wiebe, Natasha, James, Matthew T., Naugler, Christopher, Manns, Braden J., Klarenbach, Scott W., Hemmelgarn, Brenda R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415845/
https://www.ncbi.nlm.nih.gov/pubmed/30865651
http://dx.doi.org/10.1371/journal.pone.0212374
_version_ 1783403244900319232
author Tonelli, Marcello
Wiebe, Natasha
James, Matthew T.
Naugler, Christopher
Manns, Braden J.
Klarenbach, Scott W.
Hemmelgarn, Brenda R.
author_facet Tonelli, Marcello
Wiebe, Natasha
James, Matthew T.
Naugler, Christopher
Manns, Braden J.
Klarenbach, Scott W.
Hemmelgarn, Brenda R.
author_sort Tonelli, Marcello
collection PubMed
description IMPORTANCE: Higher levels of red cell distribution width (RDW) are associated with adverse outcomes, especially in selected cohorts with or at risk for chronic disease. Whether higher RDW or the related parameter standard deviation of the red blood cell distribution (SD-RBC) can predict a broader range of outcomes in the general population is unknown. OBJECTIVE: To evaluate the association of RDW and SD-RBC with the risk of adverse outcomes in people from the general population. DESIGN: Population-based retrospective cohort study. SETTING: Health care system in a Canadian province (Alberta). PARTICIPANTS: All 3,156,863 adults living in Alberta, Canada with at least one measure of RDW and SD-RBC between 2003 and 2016. Data were analyzed in September 2018. EXPOSURE: RDW and SD-RBC, classified into percentiles (<1, 1–5, 5–25, 25–75, 75–95, 95–99, >99). MAIN OUTCOMES: All-cause death, first myocardial infarction, first stroke or transient ischemic attack, placement into long-term care (LTC), progression to renal replacement therapy (initiation of chronic dialysis or pre-emptive kidney transplantation), incident solid malignancy, and first hospitalization during follow-up. RESULTS: Over median follow-up of 6.8 years, 209,991 of 3,156,863 participants (6.7%) died. The risk of death increased with increasing RDW percentile. After adjustment, and compared to RDW in the 25(th) to 75(th) percentiles, the risk of death was lower for participants in the <25(th) percentiles but higher for participants in the 75(th)-95(th) percentiles (HR 1.42, 95% CI 1.40,1.43), the 95(th)-99(th) percentiles (HR 1.86, 95% CI 1.83,1.89) and the >99(th) percentile (HR 2.18, 95% CI 2.12,2.23). Similar results were observed for MI, stroke/TIA, incident cancer, hospitalization and LTC placement, but no association was found between RDW and ESRD. Findings were generally similar for SD-RBC, except that all associations tended to be stronger than for RDW, and both lower and higher values of SD-RBC were independently associated with ESRD. CONCLUSION AND RELEVANCE: RDW and SD-RBC may be useful as prognostic markers for people in the general population, especially for outcomes related to chronic illness. SD-RBC may be superior to RDW.
format Online
Article
Text
id pubmed-6415845
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-64158452019-04-02 Red cell distribution width associations with clinical outcomes: A population-based cohort study Tonelli, Marcello Wiebe, Natasha James, Matthew T. Naugler, Christopher Manns, Braden J. Klarenbach, Scott W. Hemmelgarn, Brenda R. PLoS One Research Article IMPORTANCE: Higher levels of red cell distribution width (RDW) are associated with adverse outcomes, especially in selected cohorts with or at risk for chronic disease. Whether higher RDW or the related parameter standard deviation of the red blood cell distribution (SD-RBC) can predict a broader range of outcomes in the general population is unknown. OBJECTIVE: To evaluate the association of RDW and SD-RBC with the risk of adverse outcomes in people from the general population. DESIGN: Population-based retrospective cohort study. SETTING: Health care system in a Canadian province (Alberta). PARTICIPANTS: All 3,156,863 adults living in Alberta, Canada with at least one measure of RDW and SD-RBC between 2003 and 2016. Data were analyzed in September 2018. EXPOSURE: RDW and SD-RBC, classified into percentiles (<1, 1–5, 5–25, 25–75, 75–95, 95–99, >99). MAIN OUTCOMES: All-cause death, first myocardial infarction, first stroke or transient ischemic attack, placement into long-term care (LTC), progression to renal replacement therapy (initiation of chronic dialysis or pre-emptive kidney transplantation), incident solid malignancy, and first hospitalization during follow-up. RESULTS: Over median follow-up of 6.8 years, 209,991 of 3,156,863 participants (6.7%) died. The risk of death increased with increasing RDW percentile. After adjustment, and compared to RDW in the 25(th) to 75(th) percentiles, the risk of death was lower for participants in the <25(th) percentiles but higher for participants in the 75(th)-95(th) percentiles (HR 1.42, 95% CI 1.40,1.43), the 95(th)-99(th) percentiles (HR 1.86, 95% CI 1.83,1.89) and the >99(th) percentile (HR 2.18, 95% CI 2.12,2.23). Similar results were observed for MI, stroke/TIA, incident cancer, hospitalization and LTC placement, but no association was found between RDW and ESRD. Findings were generally similar for SD-RBC, except that all associations tended to be stronger than for RDW, and both lower and higher values of SD-RBC were independently associated with ESRD. CONCLUSION AND RELEVANCE: RDW and SD-RBC may be useful as prognostic markers for people in the general population, especially for outcomes related to chronic illness. SD-RBC may be superior to RDW. Public Library of Science 2019-03-13 /pmc/articles/PMC6415845/ /pubmed/30865651 http://dx.doi.org/10.1371/journal.pone.0212374 Text en © 2019 Tonelli et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Tonelli, Marcello
Wiebe, Natasha
James, Matthew T.
Naugler, Christopher
Manns, Braden J.
Klarenbach, Scott W.
Hemmelgarn, Brenda R.
Red cell distribution width associations with clinical outcomes: A population-based cohort study
title Red cell distribution width associations with clinical outcomes: A population-based cohort study
title_full Red cell distribution width associations with clinical outcomes: A population-based cohort study
title_fullStr Red cell distribution width associations with clinical outcomes: A population-based cohort study
title_full_unstemmed Red cell distribution width associations with clinical outcomes: A population-based cohort study
title_short Red cell distribution width associations with clinical outcomes: A population-based cohort study
title_sort red cell distribution width associations with clinical outcomes: a population-based cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415845/
https://www.ncbi.nlm.nih.gov/pubmed/30865651
http://dx.doi.org/10.1371/journal.pone.0212374
work_keys_str_mv AT tonellimarcello redcelldistributionwidthassociationswithclinicaloutcomesapopulationbasedcohortstudy
AT wiebenatasha redcelldistributionwidthassociationswithclinicaloutcomesapopulationbasedcohortstudy
AT jamesmatthewt redcelldistributionwidthassociationswithclinicaloutcomesapopulationbasedcohortstudy
AT nauglerchristopher redcelldistributionwidthassociationswithclinicaloutcomesapopulationbasedcohortstudy
AT mannsbradenj redcelldistributionwidthassociationswithclinicaloutcomesapopulationbasedcohortstudy
AT klarenbachscottw redcelldistributionwidthassociationswithclinicaloutcomesapopulationbasedcohortstudy
AT hemmelgarnbrendar redcelldistributionwidthassociationswithclinicaloutcomesapopulationbasedcohortstudy